If ARNA $9 ...OREX $18...TWICE FDA PANEL RECOMENDATIONS.
ARNAs Lorcaserin gives 5% weight loss with 182 million shares gies price tag @ $9 then OREX is 10% weight loss with ONLY 67 million O.S. SHARES gives PRICE TAG minimum $18 as FDA Panel gives twice their recommendations in past.
OREX IS A LONG WAY FROM GETTING REJECTED! Which now is the time to get out, because with 2 Spec. Drugs being approved, the FDA will not make 3 without seeing the risks addressed and better than the two approved. So in order for OREX to get Approved the BETTER see improvements when they present to the panel. I think this is the short and not the long play
Apparently, you've forgotten, augi, that OREX has a written agreement with the FDA regarding a path forward for Contrave. A clean bill of health on cardio and the drug will be approved -- it's that simple, and it's called a Special Protocol Assessment.